Department of Medical Oncology & Therapeutics Research | City of Hope National Medical Center
City of Hope National Medical Center
Location: Los Angeles, California
Type: Full Time
Required Education: MD/DO
Salary: 75th% of MGMA
Internal Number: 072022MedOnc
Department of Medical Oncology & Therapeutics Research | City of Hope National Medical Center Southern California (Duarte/Irvine Campuses & Network Sites)
City of Hope Medical Oncology Opportunities
The Department of Medical Oncology and Therapeutics Research at City of Hope is recognized for its clinical and academic excellence. Our world-renowned medical oncologists conduct innovative research to further scientific knowledge and offer patients their best clinical options.
City of Hope is an ever-expanding organization committed to bringing compassionate care to patients across Southern California.
We have several opportunities to join the Department of Medical Oncology in our clinical network.
These positions feature the following:
Primarily clinical positions working out of an outpatient clinic location, with a multi-specialty care team
Potential for incentive compensation and an excellent benefits package, including a generous retirement plan
Relocation assistance available
Clinical effort to include inpatient and outpatient services with dedicated time for administrative activities
Base salary is commensurate to experience starting plus incentives
City of Hope Medical Group (COHMG) benefits package:
Medical, Dental, Vision, STD, LTD, AD&D, life, Malpractice, CME allowance, 20 days paid vacation, 3 personal days, 18 sick days, 7 holidays, and 10 CME days
City of Hope adds 20% of base salary to your retirement account (NOT a match—you don’t contribute a penny) each year; *IRS max for 2022 is $61,000
$5,000 per year for CME-related activities (travel, meetings, etc.)
Relocation and sign-on on offered on a case-by-case basis
City of Hope is dedicated to making a difference in the lives of people with cancer, diabetes, and other serious illnesses. Our mission is to transform the future of health care by turning science into a practical benefit, and hope into reality. We accomplish this by providing outstanding care, conducting innovative research and offering vital education programs focused on eliminating these diseases.
Founded in 1913, City of Hope is one of only 51 comprehensive cancer centers in the nation, as designated by the National Cancer Institute. City of Hope has been ranked among the nation’s “Best Hospitals” in cancer by U.S. News and World Report for 14 consecutive years. City of Hope (COH) is a leading research and treatment center for cancer, diabetes and other life-threatening diseases located in Duarte, California. Over the last 100 years, City of Hope has built a legacy in Duarte of being a world leader in cancer research, treatment, and prevention. Recently, the organization extended its reach beyond Duarte to include 37 community sites in Los Angeles, Orange, Riverside, and San Bernardino counties, steadily moving it to number one in Southern California for inpatient market share and pushing its capacity limits. In 2018, City of Hope began a transformational journey with ambitious goals in the areas of patient care, value-based care and precision medicine, hematology malignancies, stem cell transplants, and meaningful innovations and cures.
Our community includes research associates, scientists, doctors, nurses, allied health professionals, graduate students, fundraising specialists, marketing professionals, volunteers and an extensive support staff. We are united by our desire to find cures, save lives and transform the future of health. Every discovery we make and every new treatment we create gives people the chance to live longer, better and more fully.
City of Hope continues to be a pioneer of patient centered care and remains committed to its tradition of exceptional care for patients, families and communities. Each day, we live out our credo:
"There is no profit in curing the body, if, in the process, we destroy the soul."
The City of Hope Environment:
We want our employees to enjoy all aspects of their professional and personal lives. Recognizing the value in diverse perspectives, we have programs that leverage engagement by bringing our professional community together. In the City of Hope environment, new employee partnerships thrive, with no barriers to freely sharing knowledge. And, in the same way we view patient care from a broad perspective, City of Hope encourages its employees, too, to enhance their view, by increasing their knowledge continually. Here at City of Hope, you will find great opportunities to provide fulfilling service, and to enjoy workplace satisfaction.
Sunny Southern California
Enjoy year-round professional sports including NFL, NBA, WNBA, NHL, MLB, and MLS
Unlimited housing options ranging from suburban to elegant neighborhoods in the heart of the city
Enjoy miles of pristine beaches in areas such as Huntington, Laguna, Newport, and Santa Monica
Home to UCSD, UCLA, UCI, USC, Cal Tech, and many other world class universities and colleges
Applicants who identify with a historically underrepresented group, including but not limited to Black/African American, Hispanic/Latinx, Indigenous/Native American, Persons of Color, or Women, are encouraged to apply.
Advanced fellowship training in Hematology/Oncology
Board-certified or eligible in medical oncology
Must have or be eligible to obtain California Medical Licensure
A commitment to provide state-of-the-art patient focused clinical care and guidance in the evolution of cancer treatments specific to leukemia should be supported by prior experience.
This position is a rare opportunity to work in a 300+ member integrated, multidisciplinary Medical Group Practice serving an NCI designated comprehensive cancer center in highly desirable Southern California, within an established and highly respected Department of Hematology & Hematopoietic Cell Transplantation. Lifestyle opportunities for individuals as well as families are unparalleled. City of Hope is an expanding institution in both numbers of patients per year as well as infrastructure investment in clinical, academic and research facilities.